[
  {
    "ts": null,
    "headline": "Abbott Laboratories Still Offers Attractive Valuation, UBS Says",
    "summary": "Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl",
    "url": "https://finnhub.io/api/news?id=accb740cf4f252c19d1f4295d1dbb44b7b00da1673319777591debedaf84e5c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759947267,
      "headline": "Abbott Laboratories Still Offers Attractive Valuation, UBS Says",
      "id": 137012963,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl",
      "url": "https://finnhub.io/api/news?id=accb740cf4f252c19d1f4295d1dbb44b7b00da1673319777591debedaf84e5c9"
    }
  },
  {
    "ts": null,
    "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
    "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
    "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759923960,
      "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
      "id": 137010062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
      "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks",
    "summary": "Abbot⁠t Labor‌atories (NYSE​:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Abbot⁠t Labor‌atories (NYSE​:ABT) has lo‌ng⁠ been a household name in the healthc‌are w‍o‌rl‍d, offering pr‌o‍ducts th​at reach milli‍o‌n‌s of people​ every day. Its operations span several major areas, includ‌ing pre⁠scription medici⁠nes⁠, med‌ical devices, d‍iagnostics, and nu‍trition.⁠ The compa‍ny’s portfolio […]",
    "url": "https://finnhub.io/api/news?id=4220957f698bfe85e141b2e908a47571c14d7c1e06ad4811424e0645da5c8e94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759904357,
      "headline": "Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks",
      "id": 137008015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbot⁠t Labor‌atories (NYSE​:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Abbot⁠t Labor‌atories (NYSE​:ABT) has lo‌ng⁠ been a household name in the healthc‌are w‍o‌rl‍d, offering pr‌o‍ducts th​at reach milli‍o‌n‌s of people​ every day. Its operations span several major areas, includ‌ing pre⁠scription medici⁠nes⁠, med‌ical devices, d‍iagnostics, and nu‍trition.⁠ The compa‍ny’s portfolio […]",
      "url": "https://finnhub.io/api/news?id=4220957f698bfe85e141b2e908a47571c14d7c1e06ad4811424e0645da5c8e94"
    }
  },
  {
    "ts": null,
    "headline": "2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid",
    "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
    "url": "https://finnhub.io/api/news?id=b9bb132b6dbf291c66b2632d39f9236af133d91d14de621c12f9e3d874026ff8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759897969,
      "headline": "2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid",
      "id": 137010063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
      "url": "https://finnhub.io/api/news?id=b9bb132b6dbf291c66b2632d39f9236af133d91d14de621c12f9e3d874026ff8"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation",
    "summary": "Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=3ad418ce70f71dac7ee397f81938b97d9364cf302168682ce1919cc1912dc0ad",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759881836,
      "headline": "Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation",
      "id": 137005042,
      "image": "",
      "related": "ABT",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3ad418ce70f71dac7ee397f81938b97d9364cf302168682ce1919cc1912dc0ad"
    }
  }
]